|
KMID : 0620920210530091356
|
|
Experimental & Molecular Medicine
2021 Volume.53 No. 9 p.1356 ~ p.1365
|
|
|
MicroRNA-338-3p as a novel therapeutic target for intervertebral disc degeneration
|
|
Jiang Hua
Moro Abu
Wang Jiaqi
Meng Dihua
Zhan Xinli
Wei Qingjun
|
|
|
Abstract
|
|
|
|
Recent studies have demonstrated the pivotal role played by microRNAs (miRNAs) in the etiopathogenesis of intervertebral disc degeneration (IDD). The study of miRNA intervention in IDD models may promote the advancement of miRNA-based therapeutic strategies. The aim of the current study was to investigate whether intradiscal delivery of miRNA can attenuate IDD development. Our results showed that miR-338-3p expression was significantly increased in the nucleus pulposus (NP) of patients with IDD. Moreover, there was a statistically significant positive correlation between the expression level of miR-338-3p and the severity of IDD. Our functional studies showed that miR-338-3p significantly influenced the expression of extracellular matrix synthesis genes, as well as the proliferation and apoptosis of NP cells. Mechanistically, miR-338-3p aggravated IDD progression by directly targeting SIRT6, a negative regulator of the MAPK/ERK pathway. Intradiscal injection of antagomir-338-3p significantly decelerated IDD development in mouse models. Our study is the first to identify miR-338-3p as a mediator of IDD and thus may be a promising target for rescuing IDD.
|
|
|
KEYWORD
|
|
|
Gene therapy, Genetic markers, Translational research
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
    
|